NCT01114568 - Study To Estimate The Relative Bioavailability of Ertugliflozin (PF-04971729, MK-8835) in Healthy Adult Participants (MK-8835-039) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Healthy

Interventions

DRUG

Ertugliflozin 10 mg tablet

A single dose of 10 mg ertugliflozin administered as 2x5 mg material sparing formulation tablets.

DRUG

Ertugliflozin OC Fast

Formulation B) Ertugliflozin 10 mg OC Fast

DRUG

Ertugliflozin OC Slow

Formulation C) Ertugliflozin 10 mg OC Slow